5-iodotubercidin has been researched along with vidarabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, IH; Hurley, MC; Lin, B | 1 |
| Cen, S; Dong, D; Guo, F; Guo, S; Li, Q; Li, X; Liu, Q; Liu, Z; Ma, L; Wei, T; Yi, D; Zhang, Y; Zhao, J | 1 |
2 other study(ies) available for 5-iodotubercidin and vidarabine
| Article | Year |
|---|---|
Regulation of deoxyadenosine and nucleoside analog phosphorylation by human placental adenosine kinase.
Topics: Adenosine Diphosphate; Adenosine Kinase; Adenosine Monophosphate; Adenosine Triphosphate; Deoxyadenosines; Female; Humans; Hydrogen-Ion Concentration; Kinetics; Methylthioinosine; Nucleosides; Nucleotides; Phosphorylation; Phosphotransferases; Placenta; Potassium Chloride; Pregnancy; Tubercidin; Vidarabine | 1985 |
5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis.
Topics: Antiviral Agents; Cell Line; COVID-19 Drug Treatment; Deoxyguanosine; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Microbial Sensitivity Tests; Nucleic Acid Synthesis Inhibitors; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Thionucleosides; Tubercidin; Vidarabine; Vidarabine Phosphate | 2022 |